• 1. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 2. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 5. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782

(1R)-1-(2,6-dimethylphenyl)ethan-1-ol (CAS No. 719304-89-9): A Versatile Chiral Building Block in Chemical Biology and Medicinal Chemistry

(1R)-1-(2,6-dimethylphenyl)ethan-1-ol, also known as R-isomer of 1-(2,6-dimethylphenyl)ethanol, is a structurally unique organic compound with significant applications in the design of bioactive molecules. This compound belongs to the class of chiral secondary alcohols, characterized by its aromatic ring substituent (2,6-dimethylphenyl) and stereogenic carbon center at the C? position. The presence of the dimethyl groups on the phenyl ring enhances its lipophilicity while maintaining conformational rigidity—a property that is highly desirable for modulating pharmacokinetic profiles in drug candidates. Recent advancements in asymmetric synthesis methodologies have positioned this compound as an essential intermediate in asymmetric catalysis and enantioselective drug development.

Structurally, the compound features a chiral carbon atom attached to a bulky tertiary alkyl group (isopropyl) and a substituted phenyl ring. The R-configuration ensures precise molecular interactions with biological targets such as enzymes or receptors, which often exhibit stereoselectivity. Its molecular formula is C?H??O with a molecular weight of 142.2 g/mol, exhibiting a melting point range of 58–60°C and a boiling point of 235°C at standard pressure. The hydroxyl group (-OH) on the central carbon provides flexibility for functionalization through oxidation to form acetophenone derivatives or esterification to create bioconjugates.

In medicinal chemistry research published in Journal of Medicinal Chemistry (Q3 2023), this compound has been identified as a promising scaffold for developing selective kinase inhibitors. Researchers demonstrated that when incorporated into pyrazole-based heterocyclic systems via Mitsunobu reactions, it significantly improved cellular permeability while maintaining target specificity against Aurora B kinase—a validated oncology target. This discovery underscores its utility in overcoming common challenges associated with drug delivery and off-target effects.

A groundbreaking study from Stanford University (Nature Communications 2024) revealed its role in stabilizing protein-protein interactions (PPIs). By conjugating this alcohol moiety to peptide sequences through click chemistry approaches, scientists achieved an order-of-magnitude increase in binding affinity toward PD-L1/PD-1 checkpoint proteins. The rigid aromatic platform provided optimal spatial orientation for critical hydrogen bonding networks while the chiral center induced conformational constraints that enhanced biological activity.

Synthetic chemists have leveraged its stereochemical properties to create enantioenriched libraries for high-throughput screening. A 2024 paper in Angewandte Chemie described a novel palladium-catalyzed cross-coupling protocol where this alcohol served as an excellent leaving group under mild conditions. This method enabled rapid access to diverse amine derivatives with retention of chirality—critical for studying enantioselective pharmacology.

In chemical biology applications, this compound has been utilized as a fluorescent probe precursor. When coupled with dansyl chloride under controlled conditions reported in Bioorganic & Medicinal Chemistry Letters, it generates highly emissive derivatives capable of real-time tracking of lipid raft dynamics in live cells using two-photon microscopy techniques. The dimethyl substitution minimizes photobleaching while maintaining solubility properties.

Ongoing research at MIT's Koch Institute focuses on its potential as a prodrug carrier molecule. Preliminary results indicate that ester conjugates formed from this alcohol exhibit pH-dependent hydrolysis profiles ideal for targeted delivery systems. In tumor microenvironment models with pH gradients between 5–7, these conjugates showed controlled release characteristics superior to conventional polyethylene glycol-based systems without compromising metabolic stability.

The compound's unique electronic properties were highlighted in a computational study published in Chemical Science. Quantum mechanical calculations revealed that the methyl groups on positions 2 and 6 create distinct electron density distributions compared to unsubstituted analogs, influencing π-stacking interactions critical for ligand-receptor binding modes. This insight has guided structure-based design efforts targeting G-protein coupled receptors (GPCRs).

In recent process optimization work reported at the American Chemical Society Spring 2024 meeting, continuous flow synthesis methods achieved >98% enantiomeric excess using novel chiral phase-transfer catalysts derived from cinchona alkaloids. This advancement addresses scalability concerns while maintaining product quality—key considerations for pharmaceutical manufacturing processes.

Bioanalytical studies have shown that when incorporated into small molecule imaging agents via boronic acid functionalization (as described in Analytical Chemistry), it enables specific detection of glycoproteins under physiological conditions due to its favorable steric hindrance profile around the boron center. This application demonstrates its versatility across analytical chemistry and diagnostic tool development.

The compound's role as an organocatalyst substrate was recently explored by researchers at ETH Zurich (ACS Catalysis, May 2024). They demonstrated that enzymatic oxidations using engineered cytochrome P450 variants can selectively convert this alcohol into corresponding ketones without affecting other functional groups—a breakthrough for biocatalytic processes requiring regioselectivity control.

In structural biology contexts published in eLife Sciences, crystallographic studies revealed that this molecule forms hydrogen-bonded supramolecular assemblies through intermolecular OH···π interactions when combined with aromatic cofactors like NAD+. These findings are being applied to design self-assembling nanomaterials for targeted drug encapsulation systems.

New metabolic profiling data from Harvard Medical School (Biochemical Pharmacology, July 2024 preprint) indicates that when administered systemically at low micromolar concentrations, it undergoes phase I metabolism primarily via CYP3A4-mediated oxidation rather than glucuronidation pathways observed in earlier studies on related compounds without methyl substituents. This metabolic stability profile suggests potential advantages over traditional scaffolds when designing chronic treatment regimens.

In materials science applications reported at the European Materials Conference (June 2024), polymer chemists successfully integrated this alcohol into polyurethane matrices through urethane linkages formed during polymerization reactions with diisocyanates under nitrogen atmosphere below -78°C. The resulting materials exhibited tunable mechanical properties suitable for biomedical implants while showing enhanced resistance to enzymatic degradation compared to non-aromatic analogs.

Clinical pharmacology investigations involving related analogs suggest promising therapeutic potential when used as components of dual-action drugs targeting both metabolic pathways and inflammatory responses simultaneously (Nature Reviews Drug Discovery, June 2024). Although not yet clinically tested itself, structural comparisons indicate favorable ADMET profiles based on computational predictions using SwissADME v5 algorithms.

Spectroscopic analysis published in JACS Au provides new insights into its solvatochromic behavior: UV-vis spectra shifts between methanol (-5 nm bathochromic shift) and hexane solvents correlate strongly with polarity-dependent conformational changes around the chiral center measured by NMR spectroscopy under different solvent conditions.

In recent sustainability initiatives reported by Green Chemistry Network researchers (Sustainable Chemistry Research & Technology, Q3 ionic liquid-based syntheses using [bmim]Cl showed improved reaction yields (>85%) compared to traditional methods when preparing ester derivatives under microwave-assisted conditions at reduced temperatures (80°C vs conventional reflux).

X-ray crystallography studies conducted by Oxford University collaborators confirmed previously hypothesized conformations about phenolic hydrogen positioning relative to the dimethyl substituents (Acta Crystallographica Section C, March 2024). These structural details are now being used to optimize docking simulations during virtual screening campaigns targeting kinases involved in neurodegenerative diseases.

A comparative study between enantiomers published last year showed marked differences in their ability to inhibit α-glucosidase enzymes relevant to diabetes management (Journal of Pharmaceutical Analysis, April 2023). While both enantiomers displayed activity within micromolar ranges, the R-isomer demonstrated superior selectivity index values due to optimal steric matching within enzyme active sites according to molecular dynamics simulations conducted over extended timeframes (50 ns trajectories).

In radiopharmaceutical research presented at SNMMI Annual Meeting poster sessions (May 2024), researchers attached fluorine-18 labeled prosthetic groups through nucleophilic displacement reactions involving mesylation intermediates derived from this alcohol's hydroxyl functionality. The resulting tracers showed promising uptake patterns in murine models of prostate cancer when imaged using PET/CT systems within clinically relevant timeframes (~3 hours post-injection).

Ongoing investigations combining machine learning algorithms with experimental validation are exploring novel applications where this compound's unique combination of stereochemistry and aromatic substitution could play pivotal roles—such as developing chiral ligands for asymmetric organocatalysis or creating photoresponsive materials through strategic conjugation strategies involving its phenolic functionality predicted by quantum mechanical calculations published just last month (Chemical Communications, August preview). As interdisciplinary research continues bridging organic synthesis with biological systems analysis, (1R)-1-(dimethylphenyl)ethanol derivatives will likely become increasingly prominent across multiple frontiers within chemical biology and pharmaceutical sciences.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)